Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 33Prostatic Neoplasms 8Triple Negative Breast Neoplasms 4Pancreatic Neoplasms 3Endometrial Neoplasms 3Carcinoma, Renal Cell 3Uterine Cervical Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pleural Effusion, Malignant 2Ovarian Neoplasms 2Neoplasms 2Mouth Neoplasms 2Lymphedema 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Infertility 2Hodgkin Disease 2Fibrosis 2Carcinoma, Medullary 2Carcinoma, Intraductal, Noninfiltrating 2Anatomic Stage III Breast Cancer AJCC v8 2Anatomic Stage I Breast Cancer AJCC v8 2Uterine Hemorrhage 1Unspecified Adult Solid Tumor, Protocol Specific 1Thyroid Nodule 1Thyroid Cancer, Papillary 1Stomatitis 1Somatostatinoma 1Soft Tissue Neoplasms 1

Interventions

temsirolimus 1binimetinib 1Valproic Acid 1Specimen Handling 1Sirolimus 1Magnetic Resonance Imaging 1Laser Therapy 1Indocyanine Green 1Immunoglobulin G 1High-Energy Shock Waves 1Enoxaparin 1Disulfides 1Cetuximab 1Biopsy 1Bevacizumab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Soft Tissue Neoplasms × High-Energy Shock Waves × Clear all
NCT02834585 2016-07-15

MUSTT

University of Genova

Unknown
70 enrolled
Sarcoma

Hypersensitivity, Sarcoma, Soft Tissue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡